A number of commonly used medicines are not included in PMP – this is due to the fact that there has not been made enough scientific research about the correlation between gene variations and the pharmacokinetics and pharmacodynamics of medicine.
Some of the medicine not described in PMP – e.g., paracetamol – are old drugs that are generically substituted and no longer of interest to medicine companies or doctors to study clinically. There will, therefore, probably never be sufficient documentation to implement the drug into PMP.
Worldwide a bit more than 230 of current medical drugs can be a target for a pharmacogenomic test. PMP have included around 200 –
the rest is in approval phase and will be integrated at a later time.